期刊文献+

莪术挥发油与氟康唑联用对阴道念珠菌药敏性的影响 被引量:2

Impact on autifungal sensitivity of a combination of Zedoray Turmeric Oil with fluconazole against vaginal Candida in vitro
下载PDF
导出
摘要 目的:评价莪术挥发油与氟康唑联合应用对致病性念珠菌的体外抗真菌药物敏感性的影响。方法:采用微量液基稀释法和棋盘微量稀释法,检测氟康唑单独及与莪术挥发油联合应用对阴道念珠菌MIC值的影响。结果:氟康唑单独和与莪术挥发油联合应用对62株念珠菌的MIC值分别为:白念珠菌(2.72±2.22)μg/mL和(2.63±2.30)μg/mL;光滑念珠菌(28.40±30.66)μg/mL和(6.00±4.21)μg/mL;近平滑念珠菌(26.00±26.48)μg/mL和(6.80±5.27)μg/mL;热带念珠菌(7.40±4.99)μg/mL和(3.40±2.63)μg/mL;克柔念珠菌(64.00±00)μg/mL和(18.00±10.07)μg/mL。结论:莪术挥发油与氟康唑联合应用能显著降低氟康唑对阴道念珠菌的MIC值。 Objective: To assess the effect on autifungal sensitivity of a combination of Zedoray Turmeric Oil with fluconazole to vaginal Candida in vitro. Methods: Susceptibility test based on NCCLS- M27 - A program was used to test MICs of fluconazole and a combination of fluconazole with Zedoray Turmeric Oil to six common isolated Candida strains. Results: The MICs of fluconazole and the combination of fluconazole with Zedoray Turmeric Oil in 62 isolated strains were C. albicans 2.72±2.22μg/mL and 2.63±2.30 μg/mL; C. glabrata 28.40±30.66μg/mL and6.00±4.21 μg/ mL ; C . parapsilosis 26.00±26.48 μg/mL and 6.80±5.27 μg/mL ; C . tr opicalis 7.40±4.99 μg/mL and 3.40±2.63 μg/mL and C. krusei 64. 00 μg/mL±00μg/mL and 18. 00±10.07 μg/mL, respectively. Conclusion: The combination of flueonazole with Zedoray Turmeric Oil may significantly, decrease the MIC of fluconazole to common vaginal Candida strains.
出处 《中国麻风皮肤病杂志》 2010年第7期468-470,共3页 China Journal of Leprosy and Skin Diseases
关键词 莪术挥发油 念珠菌 氟康唑 抗真菌药物敏感性实验 Zedoray Turmeric Oil Candida fluconazole antifungal sensitivity
  • 相关文献

参考文献9

  • 1董平,万喆,李若瑜.阿莫罗芬与特比萘芬和伊曲康唑联合对甲真菌病致病菌的体外药敏试验[J].中华皮肤科杂志,2004,37(8):478-480. 被引量:10
  • 2陈宏,温海,徐红,廖万清.伊曲康唑和特比萘芬体外联合药敏试验分析[J].中国皮肤性病学杂志,2003,17(2):99-100. 被引量:15
  • 3Marchetti O,Moreillon P,Glauser MP,et al.Potent synergism of the combination of Fluconazole and cyclosporine in Candida albicans.Antimicrob Agents Chemother 2000;44(9):2373-2381.
  • 4National Committee for Clinical Laboratory Standards.2002.Reference method for broth dilution antifungal susceptibility testing for yeasts.Approved standard M27-A2,2nd ed.National Committee for Clinical Laboratory Standards,Wayne,Pa.
  • 5Hammer KA,Carson CF,Riley TV.In vitro activity of essential oils,in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products,against Candida spp.J Antimicrob Chemotherapy 1998;42(5):591-595.
  • 6聂小华,敖宗华,尹光耀,陶文沂.提取技术对温莪术挥发油化学成分及其体外抗肿瘤活性的影响[J].药物生物技术,2003,10(3):152-154. 被引量:27
  • 7El-Din SS,Reynolds MT,Ashbee HR,et al.An investigation into the pathogenesis of vulvovaginal candidosis.Sex Transm Infect 2001;77(3):179-183.
  • 8Ribeiro MA,Dietze R,Paula CR,et al.Susceptibility profile of vaginal yeast isolates from Brazil.Mycopathologia 2000;151(1):5-10.
  • 9Vanden Bossche H,Dromer F,Improvisi I,et al.Antifungal drug resistance in pathogenic fungi.Med Mycol 1998;36(suppl 1):119-128.

二级参考文献22

  • 1Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol, 1998, 139: 665-671.
  • 2Barchiesi F, Falconi Di Francesco L, Scalise G. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother, 1997, 41: 1812-1814.
  • 3Nguyen MH, Barchiesi F, McGough DA, et al. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother, 1995, 39:1691-1695.
  • 4Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol, 2002, 40: 3999-4003.
  • 5Polak A. Combination of amorolfine with various antifungal drugs in dermatophytosis. Mycoses, 1993, 36: 43-49.
  • 6Muller J, Polak-Wyss A, Melchinger W. Influence of amorolfine on the morphology of Candida albicans and Trichophyton mentagrophytes. Clin Exp Dermatol, 1992, 17 Suppl 1: 18-25.
  • 7[1]National committee for clinical laboratory standards reference method for broth dilution antifungal susceptibility testing of yeast: approved Standard M27-A[J]. National Committee for Clinical Laboratory Standards Villanova Pa, 1997.6.
  • 8[2]Oscar M, Philippe M, Michel PG, et al. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans[J ]. Antimicrobial Agents and Chemotheraphy, 2000,44; 2373 - 2381.
  • 9[3]Ryder NS. Activity of terbinafine against serious fungal pathogens[J].Mycoses, 1999,42 (Suppl) :2115 - 2119.
  • 10[4]Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species[J ]. Med-Mycol, 2001,39(1):91-95.

共引文献47

同被引文献64

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部